Atlas Trials

A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis

Clinical trial NCT07291180 · RECRUITING

Trial details

NCT number
NCT07291180
Sponsor
Yale University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Appendiceal CancerColorectal AdenocarcinomaPeritoneal Metastases
Start date
2026-02-17
Primary completion
2027-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.